Critical analysis of studies evaluating the efficacy of infusion of L-ornithine L-aspartate in clinical hepatic encephalopathy in patients with liver failure

Annals of Hepatology

Volumn 10, Issue SUPPL. 2, 2011, Pages

  Hernández, José Luis Pérez ^a   de la Tijera, Fátima Higuera ^a   Serralde Zúñiga, Aurora Elizabeth ^a   Francis, Juan Miguel Abdo ^a  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

Chronic liver disease; Hepatic encephalopathy; LOLA infusion

Indexed keywords

AMMONIA; LACTULOSE; ORNITHINE ASPARTATE; PLACEBO;

ACUTE LIVER FAILURE; ADULT; AGED; AMMONIA BLOOD LEVEL; ANALYTICAL PARAMETERS; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEALTH STATUS; HEPATIC ENCEPHALOPATHY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; META ANALYSIS; NAUSEA; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING;

EID: 79961201697     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31610-2     Document Type: Article

References (16)

1. Gitlin N. Hepatic encephalopathy. In: Zakim D Boyer TD (eds.). Hepatology: a textbook of liver disease. Vol. 1.3rd. Ed. Philadelphia: W.B. Saunders; 1996, p. 605-17
2. Blei AT, Cordoba H. Practice Parameters Committee of the American College of Gastroenterology. Hepatic encephalopathy. Am J Gastroenterol 2001; 96: 1968-76.
3. Clemmesen JO, Kondrup J, Ott P. Splachnic and leg exchange of amino acids and ammonia in acute liver failure.Gastroenterology 2000; 118: 1131-39.
4. Lockwood AH, McDonald JM, Reiman RE. The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia. J Clin Invest 1979; 63: 449-60.
5. Felipo V, Butterworth RF. Neurobiology of ammonia. ProgrNeurobiol 2002; 67: 259-79.
6. Lai JC, Cooper AJ. Brain alphaketoglutarate dehydrogenase complex: kinetic properties, regional distribution,and effects of inhibitors. J Neurochem 1986; 47: 1376-86.
7. Olde DSW, Deutz NE, Dejong CH, Soeters PB, Jalan R. Interorgan ammonia metabolism in liver failure. Neurochem Int 2002; 41: 177-88.
8. Haussinger D. Regulation of hepatic ammonia metabolism: the intercellular glutamine cycle. Adv Enzyme Regul 1986;25: 159-80.
9. Staedt U, Leweling H, Gladisch R, Kortsik C, Hagmuller E, Holm E. Effects of ornithine aspartate on plasma ammonia and plasma amino acids in patients with cirrhosis. A double-blind, randomized study using a four-fold crossover design. J Hepatol 1993; 19: 424-30.
10. Rose C, Michalak A, Rao KV, Quack G, Kircheis G, But-terworth RF. L-ornithine L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure. Hepatology 1999; 30: 636-40.
11. Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Görtelmer R, et al. Therapeutic efficacy of Lornithine L-aspar-tate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study. Hepatology 1997; 25: 1351-60.
12. Staedt U, Leweling H, Gladisch R, Kortsik C, Hagmüller E, Holm E. Effects of L-ornithine L-aspartate on plasma ammonia and plasma amino acids in patients with cirrhosis. A double-blind, randomized study using a four-fold crossover design. J Hepatol 1993; 19: 424-30.
13. Kircheis G, Wettstein M, Dahl S, Häussinger D. Clinical efficacy of L-ornithine L-aspartate in the management of hepaticencephalopathy. Metab Brain Disease 2002; 17: 453-62.
14. Ahmad I, Khan AA, Alam A, Dilshad A, Butt AK, Shafqat F, etal. L-ornithine L-aspartate infusion efficacy in hepatic en-cephalopathy. J Coll Physicians Surg Pak 2008; 18: 684-87.
15. Acharya SK, Bhatia V, Sreenivas V, Khanal S. Efficacy of L-ornithine L-aspartate in acute liver failure: a double- blind, randomized, placebo-controlled study. Gastroenterology 2009; 136: 2159-68.
16. Abdo-Francis JM, Pérez HJL, Hinojosa RA, Hernández-Vásquez J. Use of L-ornitin L-aspartate (LOLA) reduce time of hospital stay in patients with hepatic encephalopathy. Rev Gastroenterol Mex 2010; 75(2): 135-41.